Prenatal Nifedipine Tocolysis Linked to Lower School Track at 12
The 12-year follow-up of the randomised APOSTEL 2 trial found that prenatal exposure to maintenance nifedipine tocolysis significantly reduced secondary school track placement, with only 35.4% of exposed children receiving high-track recommendations versus 44.0% in the placebo group. The dose-response pattern, with the